Accustem Sciences Inc

NEW
OTCPK:ACUT (USA)  
$ 0.55 +0.030 (+5.77%) 02:44 PM EST
At Loss
Volume:
4.60K
Avg Vol (2M):
13.03K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
4.60K
At Loss
Avg Vol (2M):
13.03K

Business Description

Description
Accustem Sciences Inc is a life sciences company that focuses on enhancing cancer patient outcomes through diagnostic, pharmaceutical, and medical device products. The company's product, StemPrintER, is a genomic platform for predicting distant recurrence risk in luminal, ER+/HER2-negative breast cancer patients. Additionally, It offers ancillary commodity testing to provide further insights. Validated in various retrospective cohorts, StemPrintER shows promise for oncology clinics. Revenue is generated through product commercialization and testing services. Operations span New York, NY, and London, UK.
Name Current Vs Industry Vs History
Cash-To-Debt 0.64
Equity-to-Asset -30.71
Debt-to-Equity -0.02
Debt-to-EBITDA -0.04
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.03
Quick Ratio 0.03
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 1.83
Name Current Vs Industry Vs History
ROA % -1003.64
ROIC % -2134.67
ROC (Joel Greenblatt) % -45966.67

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -4.29
EV-to-EBITDA -4.31
EV-to-FCF -6.17
Earnings Yield (Greenblatt) % -23.31
FCF Yield % -15.37

Financials

ACUT's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ACUT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Accustem Sciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.12
Beta 2.95
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 149.33
14-Day RSI 63.88
14-Day ATR ($) 0.063439
20-Day SMA ($) 0.415695
12-1 Month Momentum % 2.29
52-Week Range ($) 0.2159 - 0.67
Shares Outstanding (Mil) 11.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Accustem Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Accustem Sciences Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Accustem Sciences Inc Frequently Asked Questions

What is Accustem Sciences Inc(ACUT)'s stock price today?
The current price of ACUT is $0.55. The 52 week high of ACUT is $0.67 and 52 week low is $0.22.
When is next earnings date of Accustem Sciences Inc(ACUT)?
The next earnings date of Accustem Sciences Inc(ACUT) is .
Does Accustem Sciences Inc(ACUT) pay dividends? If so, how much?
Accustem Sciences Inc(ACUT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1